Search Results - "Pötschger, U."

Central nervous system relapse in high-risk stage 4 neuroblastoma: The HR-NBL1/SIOPEN trial experience by Berlanga, P., Pasqualini, C., Pötschger, U., Sangüesa, C., Castellani, M.R., Cañete, A., Luksch, R., Elliot, M., Schreier, G., Kropf, M., Morgenstern, D., Papadakis, V., Ash, S., Ruud, E., Brock, P., Wieczorek, A., Kogner, P., Trahair, T., Ambros, P., Boterberg, T., Castel, V., Valteau-Couanet, D., Ladenstein, R.

“…There is rising concern on the impact of new strategies, such as high-dose chemotherapy (HDC) and immunotherapy, on the pattern of relapse in high-risk…”
Get full text

High dose chemotherapy and autologous hematopoietic cell transplantation for Wilms tumor: a study of the European Society for Blood and Marrow Transplantation by Spreafico, F., Dalissier, A., Pötschger, U., Locatelli, F., Michon, J. M., Peters, C., Bader, P., Bisogno, G., Yeomanson, D., Willasch, A., van den Heuvel Eibrink, M., Graf, N., Dallorso, S.

“…Survival for subgroups of patients with Wilms tumor (WT), such as those who suffer from relapse, is disappointing. Some patients’ treatment plans include…”
Get full text

Incidence and severity of crucial late effects after allogeneic HSCT for malignancy under the age of 3 years: TBI is what really matters by Bresters, D, Lawitschka, A, Cugno, C, Pötschger, U, Dalissier, A, Michel, G, Vettenranta, K, Sundin, M, Al-Seraihy, A, Faraci, M, Sedlacek, P, Versluys, A B, Jenkins, A, Lutz, P, Gibson, B, Leiper, A, Diaz, M A, Shaw, P J, Skinner, R, O'Brien, T A, Salooja, N, Bader, P, Peters, C

“…Younger children are considered to be more vulnerable to late effects (LE), which prompted us to study LE in patients after haematopoietic stem cell…”
Get full text

Clinicogenomic associations in childhood Langerhans cell histiocytosis: an international cohort study by Kemps, Paul G., Zondag, Timo C. E., Arnardóttir, Helga B., Solleveld-Westerink, Nienke, Borst, Jelske, Steenwijk, Eline C., van Egmond, Demi, Swennenhuis, Joost F., Stelloo, Ellen, Trambusti, Irene, Verdijk, Robert M., van Noesel, Carel J. M., Cleven, Arjen H. G., Scheijde-Vermeulen, Marijn A., Koudijs, Marco J., Krsková, Lenka, Hawkins, Cynthia, Egeler, R. Maarten, Brok, Jesper, von Bahr Greenwood, Tatiana, Svojgr, Karel, Beishuizen, Auke, van Laar, Jan A. M., Pötschger, Ulrike, Hutter, Caroline, Sieni, Elena, Minkov, Milen, Abla, Oussama, van Wezel, Tom, van den Bos, Cor, van Halteren, Astrid G. S.

“…•Oncogenic mutation subtype appears an important driver of heterogeneity in clinical presentation of pediatric LCH.•Lesional BRAFV600E status is not a…”
Get full text

Persistence and reactivation of human adenoviruses in the gastrointestinal tract by Kosulin, K., Geiger, E., Vécsei, A., Huber, W.-D., Rauch, M., Brenner, E., Wrba, F., Hammer, K., Innerhofer, A., Pötschger, U., Lawitschka, A., Matthes-Leodolter, S., Fritsch, G., Lion, T.

“…Reactivation of persistent human adenoviruses (HAdVs) is associated with high morbidity and mortality in paediatric haematopoietic stem cell transplant (HSCT)…”
Get full text

Exhaled nitric oxide and pulmonary complications after paediatric stem cell transplantation by Fazekas, T., Eickhoff, P., Lawitschka, A., Knotek, B., Pötschger, U., Peters, C.

“…Pulmonary complications are major causes of morbidity and mortality after haematopoietic stem cell transplantation (HSCT). We hypothesise that elevated exhaled…”
Get full text

4114 POSTER Monitoring of Bone Marrow Clearing by an Automated Imaging Device (Immunofluorescence Plus Genetics) Identifies Different Risk Groups in Neuroblastoma Patients Over 18 Months by Ambros, I.M, Pötschger, U, Ziegler, A, Modritz, D, Gadner, H, Ladenstein, R, Ambros, P.R

Get full text

Monitoring of adenovirus load in stool by real-time PCR permits early detection of impending invasive infection in patients after allogeneic stem cell transplantation by Lion, T, Kosulin, K, Landlinger, C, Rauch, M, Preuner, S, Jugovic, D, Pötschger, U, Lawitschka, A, Peters, C, Fritsch, G, Matthes-Martin, S

“…Invasive adenovirus (AdV) infections are associated with high morbidity and mortality in allogeneic stem cell transplant recipients. We observed that molecular…”
Get full text

Quality Assessment of Genetic Markers Used for Therapy Stratification by Ambros, I.M., Benard, J., Boavida, M., Bown, N., Caron, H., Combaret, V., Couturier, J., Darnfors, C., Delattre, O., Freeman-Edward, J., Gambini, C., Gross, N., Hattinger, C.M., Luegmayr, A., Lunec, J., Martinsson, T., Mazzocco, K., Navarro, S., Noguera, R., O’Neill, S., Pötschger, U., Rumpler, S., Speleman, F., Tonini, G.P., Valent, A., Van Roy, N., Amann, G., De Bernardi, B., Kogner, P., Ladenstein, R., Michon, J., Pearson, A.D.J., Ambros, P.F.

“…Therapy stratification based on genetic markers is becoming increasingly important, which makes commitment to the highest possible reliability of the involved…”
Get full text

Treosulfan-based conditioning regimens for allogeneic haematopoietic stem cell transplantation in children with non-malignant diseases by Slatter, M A, Boztug, H, Pötschger, U, Sykora, K-W, Lankester, A, Yaniv, I, Sedlacek, P, Glogova, E, Veys, P, Gennery, A R, Peters, C

“…An increasing number of children with non-malignant diseases can be cured by allogeneic haematopoietic stem cell transplantation (HSCT). Treosulfan ( L…”
Get full text

Hemopoietic stem cell transplantation in thalassemia: a report from the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Registry, 2000–2010 by Baronciani, D, Angelucci, E, Potschger, U, Gaziev, J, Yesilipek, A, Zecca, M, Orofino, M G, Giardini, C, Al-Ahmari, A, Marktel, S, de la Fuente, J, Ghavamzadeh, A, Hussein, A A, Targhetta, C, Pilo, F, Locatelli, F, Dini, G, Bader, P, Peters, C

“…Allogeneic hemopoietic stem cell transplantation (HSCT) is the only method currently available to cure transfusion-dependent thalassemia major that has been…”
Get full text

Risk factors for diabetes insipidus in langerhans cell histiocytosis by Grois, N., Pötschger, U., Prosch, H., Minkov, M., Arico, M., Braier, J., Henter, J-I., Janka-Schaub, G., Ladisch, S., Ritter, J., Steiner, M., Unger, E., Gadner, H.

“…Background Diabetes insipidus (DI) is the most frequent central nervous system (CNS)‐related permanent consequence in Langerhans cell histiocytosis (LCH),…”
Get full text

Suppression of FOXO1 is responsible for a growth regulatory repressive transcriptional sub-signature of EWS-FLI1 in Ewing sarcoma by Niedan, S, Kauer, M, Aryee, D N T, Kofler, R, Schwentner, R, Meier, A, Pötschger, U, Kontny, U, Kovar, H

“…The Ewing sarcoma (ES) EWS-FLI1 chimeric oncoprotein is a prototypic aberrant ETS transcription factor with activating and repressive regulatory functions. We…”
Get full text

Chromosome 14 copy number-dependent IGH gene rearrangement patterns in high hyperdiploid childhood B-cell precursor ALL: implications for leukemia biology and minimal residual disease analysis by Csinady, E, van der Velden, V H J, Joas, R, Fischer, S, de Vries, J F, Beverloo, H B, König, M, Pötschger, U, van Dongen, J J M, Mann, G, Haas, O A, Panzer-Grümayer, E R

“…Childhood B-cell precursor acute lymphoblastic leukemia (BCP ALL) is generally a clonal disease in which the number of IGH rearrangements per cell does not…”
Get full text

28 years of high-dose therapy and SCT for neuroblastoma in Europe: lessons from more than 4000 procedures by Ladenstein, R, Pötschger, U, Hartman, O, Pearson, A D J, Klingebiel, T, Castel, V, Yaniv, I, Demirer, T, Dini, G

“…Between 1978 and 2006, the European Group for Blood and Marrow Transplantation registered 4098 high-dose therapy (HDT) procedures followed by stem cell rescue…”
Get full text

Induction death and treatment-related mortality in first remission of children with acute lymphoblastic leukemia: a population-based analysis of the Austrian Berlin-Frankfurt-Münster study group by Prucker, C, Attarbaschi, A, Peters, C, Dworzak, M N, Pötschger, U, Urban, C, Fink, F-M, Meister, B, Schmitt, K, Haas, O A, Gadner, H, Mann, G

“…In the management of the childhood acute lymphoblastic leukemia (ALL), 5% of failures are due to induction death and treatment-related deaths in first complete…”
Get full text

Radiotherapy quality assurance outcome and its correlation with survival in the SIOPEN High-Risk Neuroblastoma trial (HR-NBL1/SIOPEN). A report from the radiotherapy committee by Kelly, S.M., Pötschger, U., Arnardottir, H.B., Boterberg, T., Dieckmann, K., Popovic, M. Beck, Ladenstein, R., Gaze, M.N.

“…Local control in high-risk neuroblastoma relies on effective multi-modality treatment, including radiotherapy. We evaluated the quality of radiotherapy…”
Get full text

Mannan-binding lectin deficiency attenuates acute GvHD in pediatric hematopoietic stem cell transplantation by Heitzeneder, S, Zeitlhofer, P, Pötschger, U, Nowak, E, Seidel, M G, Hölzl, M, Lawitschka, A, Förster-Waldl, E, Matthes-Martin, S, Heja, D, Haas, O A, Heitger, A

Get full text

Langerhans cell histiocytosis in neonates by Minkov, M., Prosch, H., Steiner, M., Grois, N., Pötschger, U., Kaatsch, P., Janka-Schaub, G., Gadner, H.

“…Background To study the incidence, clinical patterns, course, and outcome of neonatal Langerhans cell histiocytosis (LCH). Procedure Retrospective analysis of…”
Get full text

Leucocyte transfusions from rhG‐CSF or prednisolone stimulated donors for treatment of severe infections in immunocompromised neutropenic patients by Peters, C., Minkov, M., Matthes‐Martin, S., Pötschger, U., Witt, V., Mann, G., Höcker, P., Worel, N., Stary, J., Klingebiel, T., Gadner, H.

“…Sepsis in profound neutropenia after chemotherapy is associated with high mortality despite appropriate antibacterial or antifungal treatment. In a prospective…”
Get full text